Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Isofol Medical announces the outcome of the Offering – trading on Nasdaq First North Premier commences today

Isofol Medical AB (publ), a clinical stage pharmaceutical company, hereby announces that the offering of newly issued shares in the Company (the “Offering”) was substantially oversubscribed. The Offering attracted strong interest among Swedish and international investors. The listing on Nasdaq First North Premier has been successful and the trading commences today.  Anders Rabbe, Managing Director, comments:“The large interest shown in becoming a shareholder in Isofol, both from investors in Sweden, Europe and in the US, is a strong signal that Isofol’s development of Modufolin® rests

SDLP - Amendments to Certain Credit Facilities

London, United Kingdom, April 4, 2017 - Seadrill Partners ("SDLP or the Company") announces today that Seadrill Limited, on behalf of SDLP, and its banking group have agreed to extend a series of key dates as part of Seadrill Limited's ongoing restructuring efforts.  Seadrill Limited has reached agreement to extend the milestone to implement a restructuring plan from 30 April to 31 July 2017 and also to extend the related covenant amendments and waivers expiring on 30 June 2017 to 30 September 2017. These covenants relate to the following secured credit facilities where both parties are

Nel ASA: Cancellation of subsequent offering

(Oslo, 4 April 2017) Reference is made to the stock exchange notice of 28 February 2017 regarding the completion of a private placement (the "Private Placement") and subsequent offering (the "Subsequent Offering") of up to 10 000 000 shares directed towards Nel ASA's ("Company") shareholders as of 27 February 2017 who were not allocated shares in the Private Placement. The Company has decided not to initiate the Subsequent Offering. Since the completion of the Private Placement, the Company's shares have traded on the Oslo Stock Exchange, with a sufficient trading volume, at prices below

SDRL - Amendments to Secured Credit Facilities

Hamilton, Bermuda, April 4, 2017 - Seadrill Limited ("Seadrill or the Company") announces today that it has reached agreement with its banking group to extend a series of key dates as part of the Company's ongoing restructuring efforts.  The Company has reached an agreement to extend the milestone to implement a restructuring plan from 30 April to 31 July 2017 and also to extend the related covenant amendments and waivers expiring on 30 June 2017 to 30 September 2017.  Finally, the Company has also received lender consent to extend the maturity dates of the following three facilities: 1.

BAKKAFROST: Q1 2017 TRADING UPDATE

Harvest volumes in Q1 2017 are Farming North 9.1 thousand tonnesFarming West 4.1 thousand tonnesTotal Q1 2017 13.2 thousand tonnes The harvest volumes are provided in head on gutted (HOG) equivalents. Feed sales in Q1 2017 are 19.5 thousand tonnes. Havsbrún sourced 106.6 thousand tonnes of raw materials in Q1 2017. The full Q1 2017 report will be released on 23 May 2017 at 06:00 CET. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 23 50 60 (mobile) This information is subject of the

Restamax Plc: RESTAMAX'S FINANCIAL STATEMENTS, CORPORATE GOVERNANCE STATEMENT AND REMUNERATION STATEMENT FOR 2016 HAVE BEEN PUBLISHED

Restamax Plc STOCK EXCHANGE RELEASE, 4 April 2017 at 8:00 Restamax's financial statements, corporate governance statement and remuneration statement for 2016 have been published Restamax Plc's financial statements, annual report, auditor's report, corporate governance statement and remuneration statement for the financial period that ended on 31 December 2016 have been published today on 4 April 2017. The documents are attached to this release as PDF files, and they are available on the Group's website at www.restamax.fi in Finnish and English. The financial statements for

ABB to acquire B&R

Zurich, Switzerland, April 4, 2017 - Shaping leadership in industrial automation· Acquisition of B&R (Bernecker + Rainer Industrie-Elektronik GmbH) will close ABB’s historic gap in machine and factory automation · Creating a uniquely comprehensive automation portfolio for customers globally · B&R is a proven innovation leader in Programmable Logic Controllers (PLC), Industrial PCs (IPC) and servo motion-based machine and factory automation · B&R delivered a revenue CAGR of 11% over last two decades and annual sales of >$600 million[1] 

Secret recording reveals extrajudicial killings in Bangladesh

A unique recording, that the Swedish Radio has access to, reveals suspected extrajudicial killings and human rights violations in Bangladesh. In the recording, that Swedish Radio today can publish excerpts from, a high ranking officer in the elite police force, Rapid Action Battalion (RAB) reveals the working methods of RAB. According to the report the measures are used on people who RAB suspects of serious crimes but who they consider too difficult to convict in a trial or impossible to rehabilitate. The investigative report published today is based on a two hour long

Fast-growing affiliate company with global focus

The online casino market online is growing rapidly right now around the world. Only in Sweden a new online casino is launched each week and the competition for new players is incredibly tough. In order to attract new players the casinos are forced to either invest heavily in advertising or to offer generous welcome bonuses for new players. Because of the wide range of online casinos on the market comparison sites that drives traffic to the casinos have become increasingly more popular. A very successful comparison site is Casinomir.com and they have the ambition to become the world's leading

Elekta and Varian settle patent litigation

STOCKHOLM, April 3, 2017 – Elekta (EKTA-B.ST) and Varian Medical Systems (NYSE: VAR) have reached a confidential settlement agreement to end ongoing patent litigation involving technology used for radiation oncology and the treatment of cancer. Varian and Elekta resolved the multi-year disputes in the United States, Germany, and the United Kingdom, including the suit brought by Elekta AB and William Beaumont Hospital, with no payments exchanged by the plaintiffs and defendants and no future financial obligations. The two companies have been in litigation since 2015. # # # For further

Norwegian competition authority approves Telia Company’s acquisition of Phonero

The Norwegian competition authority has today approved Telia Company’s acquisition of Phonero. The transaction will strengthen Telia’s position in the Norwegian enterprise segment.“I’m very happy to see that we are making good progress in Norway which is a market where I see a great potential for Telia Company to invest more and give more to our customers and society. The acquisition of Phonero will strengthen our position and make us an even stronger challenger in the enterprise segment,” says Johan Dennelind, President and CEO Telia Company.      Telia has in record time made

AniCura significantly expands its veterinary offering in the Netherlands with the acquisition of Sterkliniek Dierenartsen

AniCura, one of Europe’s leading providers of high-quality veterinary care for companion animals, acquires Sterkliniek Dierenartsen BV, a nationwide veterinary group comprising 82 veterinary clinics well-known for their quality focus. The acquisition strengthens AniCura's position as the leading provider of veterinary care in the Netherlands.AniCura was founded in 2011 as the first merger of animal hospitals in Sweden. Following its inception, the company has grown rapidly to currently comprise 150 animal hospitals and veterinary clinics throughout Europe. AniCura entered the Dutch market

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 27/2017Reykjavík, 3 April 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 November 2017. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration

Eniro presents recapitalization plan

Translation of Swedish press release distributed April 3, 2017, 07.45 CET  · Offering to holders of convertibles and preference shares to exchange convertibles to ordinary shares · New issue of ordinary shares for SEK 275 M · Decrease in interest-bearing loans by SEK 828 M if owners of convertibles and preference shares accept the offer and the new issue of ordinary shares of SEK 275 M is carried outStockholm Nasdaq-listed Eniro AB (publ) (“Eniro” or “the Company”)[1] 

United Bankers Oyj: SHARE REPURCHASE 3.4.2017

United Bankers Oyj     STOCK EXCHANGE ANNOUNCEMENT     3.4.2017 SHARE REPURCHASE 3.4.2017 In the Helsinki Stock Exchange Trade date 3.4.2017Bourse trade BUYShare UNIAVAmount 25 sharesAverage price/ share 34.6500 EURTotal cost 866,25 EUR United bankers Oyj now holds a total of 8 193 sharesincluding the shares repurchased on 3.4.2017. On behalf of United Bankers Oyj Nordea Bank AB (publ), Finnish BranchJanne Sarvikivi         Julius Summanen

DiviTum® results in blockbuster drug study presented at AACR

Uppsala, Sweden, April 3 2017. The latest data of the DiviTum® assay as an efficacy marker of CDK4/6 inhibition was presented in an oral session by Dr. Geoffrey Shapiro, Dana-Farber Cancer Institute, at the 2017 American Association for Cancer Research (AACR) Annual Meeting.The results, presented as part of an ongoing clinical trial (NCT02022982) at the Dana-Farber Cancer Institute, demonstrate that the DiviTum® assay for determining Thymidine Kinase Activity (TKA) can be a practical, non-invasive tool for monitoring the efficacy of CDK4/6 inhibitors. There is a great need for a method that

Exchange rates for the first quarter of 2017

The net foreign exchange impact of the Kindred Group’s main trading currencies against its reporting currency of GBP is shown in the tables below. While this has no material impact on the underlying development in Kindred Group’s business, it does affect the reported results when translated into GBP. The weighted average impact of GBP against Kindred Group’s main currencies was a positive impact on Gross winnings revenue of approximately 10-11 per cent in the first quarter of 2017 compared to the same period of 2016.Balancesheetrates:Rate to 31-Mar-16 31-Mar-17

UTA assistant professor awarded American Physical Society’s Mitsuyoshi Tanaka Dissertation Award in Experimental Particle Physics

The American Physical Society has awarded Benjamin Jones, assistant professor of Physics at The University of Texas at Arlington, the Mitsuyoshi Tanaka Dissertation Award in Experimental Particle Physics, which is widely considered the most prestigious dissertation award in the field. Jones received the award for his doctoral thesis from Massachusetts Institute of Technology, “Sterile Neutrinos in Cold Climates,” which was based on his research on the IceCube experiment at the South Pole. IceCube is an international collaboration of scientists from 48 institutions in 12 countries,

Orkla ASA: Mandatory notification of trade - options

On 3 April, in connection with Orkla's former management option programme, 25,000 options in Orkla-shares were exercised at a strike price of NOK 40.03 per share.After this transaction, the total number of options issued in Orkla shares under the management option programme is 575,000. Orkla owns 2,333,135 treasury shares.Orkla ASAOslo, 3 April 2017Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147   This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Notice of Annual General Meeting 2017 of AB Fagerhult (publ)

Shareholders of AB Fagerhult (publ), Corporate Identity Number 556110-6203, are hereby given notice of the Annual General Meeting of the Company to be held on Wednesday, 3 May 2017 at 5:00 p.m. in Fagerhult, Åvägen 1, SE-566 80, Habo, Sweden.A.     REGISTRATION Shareholders wishing to take part in the Annual General Meeting (AGM) must be registered in the shareholders’ register kept by Euroclear Sweden AB no later than Wednesday, 26 April 2017 and register their attendance with Fagerhult no later than 26 April 2017. Registration can be done by e-mail at arsstamma@fagerhult.se, by

Total Voting Rights

3 April 2017 15:00 BST Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.  As at 31 March 2017 the issued share capital of AstraZeneca PLC with voting rights is 1,265,602,163 ordinary shares of US$0.25.  No shares are held in Treasury.  Therefore, the total number of voting rights in AstraZeneca PLC is 1,265,602,163. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

There are no items matching the current filter
There are no more items matching the current filter
Back to top